Humana Inc Outlook |
On February 11 2025 the Humana Inc provided following guidance
nnHumana Inc. Financial Results for Fourth Quarter 2024 and Full Year 2025 Guidancenn
nnLOUISVILLE, Ky.nn – Humana Inc. (NYSE: HUM) has officially released its financial results for the fourth quarter of 2024 as well as a comprehensive overview of its performance for the entire fiscal year. The company compared its outcomes for the quarter and the fiscal year ended December 31, 2024, with those from the same periods in 2023.
While the detailed financial figures and comparisons are presented in accompanying tables, key metrics regarding consolidated pretax results and earnings per share (EPS) are noteworthy. Specifically, the company reported its consolidated income (or loss) before taxes, which reflects the overall financial performance before accounting for income taxes and equity in net losses.
Additionally, Humana Inc. has provided its financial outlook for the full year of 2025. Although the text does not unveil specific figures or in-depth details, the revised guidance serves to inform stakeholders about the company's anticipated financial trajectories as it navigates the upcoming fiscal periods.
In summary, as detailed in the latest report, Humana is actively managing its financial health while paving the way for future growth strategies and commitments to its stakeholders for 2025.,
|
On January 10 2025 the Humana Inc provided following guidance
Humana Inc. (NYSE: HUM) is scheduled to unveil its financial results for the fourth quarter of 2024 on February 11, 2025. The results will be made public at 6:30 a.m. Eastern Time, along with a set of prepared remarks from management available in PDF format for stakeholders and interested parties.
Located in Louisville, Kentucky, Humana will also conduct a live question and answer session at 9:00 a.m. Eastern Time on the same day. During this session, company executives will provide insights into the quarterly financial performance and share their earnings projections for the upcoming year, 2025.
For those who wish to participate in the QandA session via telephone, prior registration is required. Interested participants can sign up in advance by following the provided registration link. This event promises to be an informative occasion for investors and s looking to understand Humana's outlook and strategic direction for the year ahead.,
|
On October 30 2024 the Humana Inc provided following guidance
nnHumana Inc. Reports Third Quarter 2024 Financial Results and Updates Full-Year Guidancenn
nnLouisville, KY – October 30, 2024nn – Humana Inc. (NYSE: HUM) has today released its financial results for the third quarter of 2024, along with an update on its guidance for the full year. While the company has shared insight into its performance over the last quarter, it has not disclosed specific details relating to the adjusted financial guidance for fiscal year 2024.
In the report, Humana highlighted its consolidated pretax income and diluted earnings per share (EPS) for the quarter ending September 30, 2024 (referred to as 3Q24), in comparison to the same quarter in the previous year (3Q23). Additionally, the report includes a year-to-date analysis of financial performance for the first nine months of 2024 (YTD 2024) compared to the same period in 2023 (YTD 2023).
The breakdown of the consolidated income before income taxes and its equity in net earnings—defined as pretax results—has been summarized in the tables accompanying the report.
The financial results reveal substantial metrics that reflect the company’s ongoing operations and strategic positioning in the healthcare sector.
Investors and stakeholders are encouraged to review the accompanying tables for a detailed perspective on Humana’s financial performance across these comparative periods. The anticipated guidance for the full year of 2024 remains a focal point for s and market watchers, with further information expected to be made available in subsequent communications from the company.
As Humana continues to navigate the complexities of the healthcare market, the company remains committed to delivering value to its members and shareholders alike.
### Detailed Financial Metrics Overview
- nnQuarter ended September 30, 2024 (3Q24)nn
- nnQuarter ended September 30, 2023 (3Q23)nn
- nnYear-to-Date-2024 (YTD 2024)nn
- nnYear-to-Date-2023 (YTD 2023)nn
nnPlease refer to the official report tables for comprehensive numeric details and performance metrics.nn
Humana is dedicated to enhancing its strategic objectives and will provide updates on performance and guidance as more information becomes available.,
|
On July 31 2024 the Humana Inc provided following guidance
Humana Inc. has recently released its financial results for the second quarter of 2024, affirming its adjusted financial guidance for the entire year. While the specific figures associated with this guidance have not been disclosed in the announcement, the company has expressed confidence in its performance outlook for fiscal 2024.
Headquartered in Louisville, Kentucky, Humana Inc. (traded under the ticker NYSE: HUM) has provided a detailed comparison of its consolidated pretax results and diluted earnings per share (EPS) for the quarter ending June 30, 2024 (2Q24), in relation to the same quarter from the previous year (2Q23). Additionally, the report includes a year-to-date (YTD) comparison for the first half of 2024 versus the same period from 2023.
The consolidated income figures, which account for income before income taxes and equity in net earnings, are presented in millions of dollars for both the current and prior year periods as outlined in the tables that accompany the report.
Overall, these results highlight Humana's ongoing commitment to achieving its financial targets as it navigates the market landscape throughout 2024.
|
On June 27 2024 the Humana Inc provided following guidance
### Humana Inc. to Announce Second Quarter 2024 Financial Results on July 31, 2024
nnLouisville, Ky.nn - Humana Inc. (NYSE: HUM) has officially announced that it will release its financial results for the second quarter of 2024 on July 31, 2024. Along with these results, Humana will provide prepared management remarks in a downloadable PDF format.
At 6:30 a.m. Eastern time on the day of the release, the company will make the financial results and management remarks available to the public. Following this, Humana will hold a live question and answer session at 9:00 a.m. Eastern time. This session is intended to provide additional insights into the financial results and discuss the earnings guidance for the entire year of 2024.
Although specific financial guidance figures were not disclosed in the announcement, the live session will offer an opportunity for s and investors to gain clarity on these metrics and the company's future outlook.
To participate in the live QandA session via telephone, registration in advance is required. Interested parties can register using the provided link.
For those interested in the financial health and future projections of Humana Inc., this session will be an important event.
|
On April 24 2024 the Humana Inc provided following guidance
Humana Inc. reported its financial results for the first quarter of 2024, affirming its full-year adjusted financial guidance. The consolidated pretax results and net earnings per share for the quarter ended March 31, 2024, were compared to the same quarter in 2023. The company reported a consolidated income before income taxes and equity in net earnings of $1.014 billion in 1Q24, compared to $1.614 billion in 1Q23 under Generally Accepted Accounting Principles (GAAP). Additionally, there was $16 million in amortization associated with identifiable intangibles in 1Q24, compared to $18 million in 1Q23.
Humana Inc. remains confident in its financial performance and outlook for the full year of 2024. The company continues to focus on delivering value to its shareholders and providing high-quality healthcare services to its customers.
|
On January 3 2024 the Humana Inc provided following guidance
Humana Inc., a leading healthcare company, has announced that it will be releasing its financial results for the fourth quarter of 2023 on February 5, 2024. The announcement states that the results will be made public at 6:30 a.m. Eastern time, followed by a conference call at 9:00 a.m. Eastern time to discuss the financial performance for the quarter as well as provide earnings guidance for the year 2024.
Those interested in participating in the conference call via telephone are encouraged to register in advance using the provided link, which is https://register.vevent.com/register/BI4ed0098679fd435e8af0ab344fa47655. Upon registration, participants will receive the necessary details for joining the call.
By releasing its financial results and hosting a conference call, Humana Inc. aims to provide transparency and insight into its performance during the fourth quarter of 2023 and its expectations for the upcoming year. This information will be valuable for investors, s, and other stakeholders in assessing the company's financial health and future prospects.
|
On November 1 2023 the Humana Inc provided following guidance
Humana Inc., a leading healthcare company, released its financial results for the third quarter of 2023. The company reported consolidated pretax results and diluted earnings per share (EPS) for the quarter and the nine months ended September 30, 2023, compared to the same periods in 2022. The financial details are provided in the following tables:
Consolidated Income before Income Taxes and Equity in Net Earnings (Pretax Results) (in millions)
| | 3Q23 | 3Q22 |
|--------------|-------------|-------------|
| Pretax Results | (a) | (a) |
| In millions | | |
|--------------|-------------|-------------|
| | | |
The company reported (a) for the third quarter of 2023 (3Q23) and (a) for the third quarter of 2022 (3Q22).
Furthermore, Humana reported its consolidated pretax results and diluted EPS for the nine months ended September 30, 2023 (YTD 2023) and the nine months ended September 30, 2022 (YTD 2022). The results are as follows:
Consolidated Income before Income Taxes and Equity in Net Earnings (Pretax Results) (in millions)
| | YTD 2023 | YTD 2022 |
|--------------|--------------|--------------|
| Pretax Results | (a) | (a) |
| In millions | | |
|--------------|--------------|--------------|
| | | |
The company reported (a) for the nine months ended September 30, 2023 (YTD 2023) and (a) for the nine months ended September 30, 2022 (YTD 2022).
Humana Inc. also affirmed its full-year 2023 adjusted EPS guidance, indicating confidence in its financial performance for the rest of the year. The company remains committed to delivering value to its shareholders and providing quality healthcare services to its customers.
|
|
|
|
